The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> April 29, 2025

Interview with the Chairman: CytoMed Therapeutics Ltd. (NASDAQ:GDTC)

Choo Chee Kong
Choo Chee Kong has been Chairman of CytoMed Therapeutics Ltd. since its incorporation in March 2018. Mr. Choo has over 20 years of experience in corporate finance. He is presently the executive vice chairman of CNMC Goldmine Holdings Limited (CNMC Group) which has been listed on the SGX-ST (SGX:5TP) since 2008 where he is responsible for the formulation of the strategic direction and expansion plans as well as the corporate governance of CNMC Group. He previously worked at DBS Bank Ltd of Singapore from 1986 to 2000. In 2000, Mr. Choo started his own corporate advisory and stockbroking boutique, Westcomb Financial Group Limited, which he listed on SGX-ST in 2004 (SGX:5EC) and served as its Chief Executive Officer from 2000 to 2008. He served as an independent director at SGX-ST listed Second Chance Properties Ltd (SGX:528) from February 2009 to November 2015 and SGX-ST listed FDS Networks Group Ltd (SGX:F07) from June 2008 to March 2015. He also served as a non-executive director at SGX-ST listed Advance SCT Limited (SGX:5FH) from May 2012 to June 2015. He started his career in October 1981 as a Project Engineer with Esso Singapore Pte Ltd. Mr. Choo received a Bachelor of Engineering in Mechanical Engineering (First Class Honours) from University of Liverpool (United Kingdom) in July 1981 and a Master in Business Administration from the University of Bradford (United Kingdom) in December 1985. Profile
Word count: 3,072

TWST: Let’s start with a brief history and overview of the company, including when and why it was founded.

Mr. Choo: Well, CytoMed was set

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
GE Aerospace (General Electric Company)
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the Chairman, President and CEO: Puma Biotechnology, Inc. (NASDAQ:PBYI)
Interview with the President and CEO: NeurAxis, Inc. (NYSEAMERICAN:NRXS)
Interview with the Chairman and CEO: Mira Pharmaceuticals, Inc. (NASDAQ:MIRA) and Telomir Pharmaceuticals, Inc. (NASDAQ:TELO)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Asymmetric Risk/Reward at Core of Multi-Asset Strategy
Dividend Growth Strategy Favors High-Quality Financials
Screening for 10% Dividend Growth Over 10 Years
ANALYST INTERVIEWS
Small Cap Med-Tech Names Are More Insulated from Tariff Fallout
Penumbra and AngioDynamics Among Top Med-Tech Sector Picks
Onshoring Drug Manufacturing Is Critical, But Not Easy
Since 1963
© The Wall Street Transcript 2016, 2025
Terms and Conditions
Privacy Policy